PATH's Drug Development Program

The Drug Development program represents a key innovation platform at PATH. Guided by a passion for health equity, we work with public- and private-sector stakeholders to develop and advance medicines for diseases disproportionately affecting women and children in low-resource settings. Areas of focus include enteric and diarrheal diseases, neglected tropical diseases, and maternal and child health.

Publication date: August 2017

PATH's Drug Development Program

105.5 KB PDF

Hard copies are not available. 

View Resource